Form 8-K - Current report:
SEC Accession No. 0001144204-12-006320
Filing Date
2012-02-07
Accepted
2012-02-07 12:50:55
Documents
5
Period of Report
2012-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v301517_8k.htm 8-K 29634
2 EXHIBIT 10.1 v301517_ex10-1.htm EX-10.1 350694
3 EXHIBIT 10.2 v301517_ex10-2.htm EX-10.2 104208
4 EXHIBIT 10.3 v301517_ex10-3.htm EX-10.3 110137
5 EXHIBIT 10.4 v301517_ex10-4.htm EX-10.4 174461
  Complete submission text file 0001144204-12-006320.txt   770263
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30975 | Film No.: 12576653
SIC: 3826 Laboratory Analytical Instruments